Sol Sherry
Sol Sherry publishes mostly in Cardiology and Cardiovascular Medicine, Molecular Biology and Internal Medicine, on topics such as Venous Thromboembolism Diagnosis and Management, Blood properties and coagulation and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #63,697 of 7,710,434 ranked researchers
- Rank in United States
- #24,516 of 1,627,098
- Works
- 159
- Citations
- 10k
- Citations per work
- 62.9
What does Sol Sherry research?
Sol Sherry's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7446.5%
- Medicine7446.5%
- Everything else6842.9%
- Life Sciences1710.6%
- 1Cardiology and Cardiovascular Medicine15% of their works
- 2Molecular Biology11% of their works
- 3Internal Medicine9% of their works
- 4Pulmonary and Respiratory Medicine8% of their works
- 5Hematology8% of their works
- 6Surgery7% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Blood properties and coagulation
- Antiplatelet Therapy and Cardiovascular Diseases
- Protease and Inhibitor Mechanisms
- Acute Myocardial Infarction Research
- Enzyme function and inhibition
- Enzyme Production and Characterization
- Blood Coagulation and Thrombosis Mechanisms
Which keywords describe Sol Sherry's research?
The keywords of their largest research topics: Antithrombotic Therapy, Hemostasis, Pulmonary Embolism, Venous Thromboembolism, Fibrinogen, Transglutaminases, Aspirin and Clopidogrel.
- Thrombin
- Microbial Enzymes
- Inhibitors
- Myocardial Infarction
- Tissue Inhibitors of Metalloproteinases
- Clopidogrel
- Transglutaminases
- Venous Thromboembolism
- Hemostasis
- Antithrombotic Therapy
- Pulmonary Embolism
- Fibrinogen
- Aspirin
- Matrix Metalloproteinases
- Acute Coronary Syndromes
- Carbonic Anhydrases
- Biotechnological Applications
- Protease-Activated Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Antithrombotic Therapy452 topics
- Hemostasis372 topics
- Pulmonary Embolism331 topic
- Venous Thromboembolism331 topic
- Fibrinogen251 topic
- Transglutaminases251 topic
- Aspirin241 topic
- Clopidogrel241 topic
- Matrix Metalloproteinases201 topic
- Tissue Inhibitors of Metalloproteinases201 topic
- Acute Coronary Syndromes191 topic
- Myocardial Infarction191 topic
- Carbonic Anhydrases151 topic
- Inhibitors151 topic
- Biotechnological Applications121 topic
- Microbial Enzymes121 topic
- Protease-Activated Receptors121 topic
- Thrombin121 topic
Where does Sol Sherry work?
Sol Sherry's main affiliation in the publication record is Temple University, United States.
How many publications and citations does Sol Sherry have?
OpenAlex counts 159 works and 9,999 citations for Sol Sherry, an h-index of 58, ranking #63,697 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sol Sherry. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.